Roche launches the cobas ® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Rochelaunches thecobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient careHandheld blood glucose management device designed around the specific needs of healthcare professionals working in a range of care settingsFirst diagnostic solution at the point of care to serve as a digital platform connecting developers of digital health software and applications to healthcare professionalsNew system simplifies workflows and equips healthcare professionals with valuable clinical insights to deliver better patient careBasel, 12 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas ® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performan ce blood glucose meter with simple usability and expanded digital capabilities similar to that of a smartphone.Glucose is among the most important biomarkers to assess patient health and predict, diagnose and manage metabolic disorders ¹. In particular, the management of blood glucose in patients is critical to preventing acute and chronic complications that may lead to increased morbidity, mortality and healthcare costs2, 4, 5, 6. Against the backdrop of a rising epidemic of diabetes3 ...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news